REFERENCES
- World Health Organization. New influenza A (H1N1) virus: Global epidemiological situation, June 2009. Wkly Epidemiol Rec. 2009;84:249–257.
- ECDC Interim Guidance. Use of specific pandemic influenza vaccines during the H1N1 2009 pandemic. Stockholm: ECDC; 2009. Available at: http://www.ecdc.europa.eu/en/publications/Publications/0908_GUI_Pandemic_Influenza_Vaccines_during_the_H1N1_2009_Pandemic.pdf. Accessed January 24, 2010.
- WHO. Weekly Epidemiological Record: Strategic Advisory Group of Experts on Immunisation (SAGE) – Report of the extraordinary meeting on the influenza A(H1N1) 2009 pandemic. Available at: http://www.who.int/wer/2009/wer8430.pdf. Accessed January 24, 2010.
- Hellenic Center of Disease Control (KEEΛ). Available at: http://www.keel.org.gr/keelpno/2009/home/ierarx_hd.pdf. Accessed January 24, 2010.
- Hellenic Center of Disease Control (KEEΛ). Press release 30. 2009. Available at: http://www.keel.org.gr/keelpno/2009/id907/deltio_typou_301109.pdf. Accessed January 24, 2010.
- CDC. Use of influenza A (H1N1) 2009 monovalent vaccine: Recommendations of the advisory committee on immunization practices (ACIP), 2009. MMWR Recomm Rep. 2009; 58(RR–10): 1–8.
- Marcelli D, Marelli C, Richards N. Influenza A(H1N1)v pandemic in the dialysis population: First wave results from an international survey. Nephrol Dial Transplant. 2009;24: 3566–3572.
- Hellenic Center of Disease Control (KEEΛ). Press release 26 Jan 2010. Available at. http://www.keel.org.gr/keelpno/2010/id907/deltio_typou_20100126.pdf. Accessed January 27, 2010.
- Wicker S, Rabenau HF, Doerr HW, Allwinn R. Influenza vaccination compliance among health care workers in a German university hospital. Infection. 2009;37:197–202.
- Blank PR, Schwenkglenks M, Szucs TD. Disparities in influenza vaccination coverage rates by target group in five European countries: Trends over seven consecutive seasons. Infection. 2009;37:390–400.
- Lau JT, Yeung NC, Choi KC, Cheng MY, Tsui HY, Griffiths S. Acceptability of A/H1N1 vaccination during pandemic phase of influenza A/H1N1 in Hong Kong: Population based cross sectional survey. BMJ. 2009;339:b4164.
- WHO. Recommended viruses for influenza vaccines for use in the 2010–2011 northern hemisphere influenza season. Available at: http://www.who.int/csr/disease/influenza/recommendations2010_11north/en/index.html. Accessed April 20, 2010.
- Focetria, Summary of product characteristics. Available at: http://www.ema.europa.eu/humandocs/PDFs/EPAR/focetria/emea-combined-h710en.pdf. Accessed January 24, 2010.
- Hellenic Center of Disease Control (KEEΛ). Press release 21 Nov 2009. Available at: http://www.keel.org.gr/keelpno/2009/id907/deltio_211109.pdf. Accessed January 24, 2010.
- Lam AY, Chung Y. Establishing an on-site influenza vaccination service in an assisted-living facility. J Am Pharm Assoc (2003). 2008;48:758–763.
- Gazmararian JA, Coleman M, Prill M, Influenza vaccination of health care workers: Policies and practices of hospitals in a community setting. Am J Infect Control. 2007;35: 441–447.
- Chittaro M, Turello D, Calligaris L, Impact of vaccinating HCWs on the ward and possible influence of avian flu threat. Infection. 2009;37:29–33.
- Greenberg ME, Lai MH, Hartel GF, Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med. 2009;361:2405–2413.
- Liang XF, Wang HQ, Wang JZ, Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: A multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2010;375:56–66.
- WHO. Pandemic (H1N1) 2009 briefing note 16: Safety of pandemic vaccines: Geneva: 2009. Available at: http://www.who.int/csr/disease/swineflu/notes/briefing_20091119/en/index.html. Accessed January 24, 2010.
- Clark TW, Pareek M, Hoschler K, Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N Engl J Med. 2009;361:2424–2435.
- Scharpé J, Peetermans WE, Vanwalleghem J, Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: An open-label trial. Am J Kidney Dis. 2009;54:77–85.